Skip to main content
. Author manuscript; available in PMC: 2016 Jul 7.
Published in final edited form as: Nutr Cancer. 2016 Jan 15;68(1):154–164. doi: 10.1080/01635581.2016.1115104

Figure 3.

Figure 3

Expression of miR-155 targets in response to genistein. MDA-MB-435 or Hs578t cells were treated with vehicle or genistein for 48 h. Lysates were western blotted for the indicated proteins. A: Representative Western blots. B: Fold changes in protein expression compared to vehicle as calculated from the integrated density of positive bands normalized for actin expression. Values shown are the mean ± SEM for N = 3. *P < 0.05.